CLINICAL_TRIALS
trial_result
· 2009-04-01
Clinical Trial Update: A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus [Phase 1]
Summary
A Phase 1 trial evaluating NBI-6024 in adults and adolescents with new-onset Type 1 Diabetes Mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocrine Biosciences | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED